
As a retinal expert, Ferrucci discusses some emerging retinal therapies that excite him.
Dr. Ferrucci is Chief of optometry at the Sepulveda VA, as well as a professor at the Southern California College of Optometry. He currently serves on the advisory board for Maculogix.
As a retinal expert, Ferrucci discusses some emerging retinal therapies that excite him.
Steve Ferrucci, OD, FAAO, discussed the detection and treatment of geographic atrophy during his AAOpt 2024 lecture, "Imaging Techniques and Emerging Therapies for Geographic Atrophy."
Dr. Ferrucci summarizes his Vision Expo West presentations and shares clinical pearls for managing retinal cases.
Steven Ferrucci, OD, FAAO, discusses imaging techniques and treatment options for geographic atrophy as part of his AAOpt presentation alongside Carolyn Majcher, OD, FAAO.
The 2023 CRU Eye Symposium in Napa Valley brings exciting presentation topics, including the retina and genetic testing.
Diagnose, monitor, comanage—optometrists support patients throughout all stages of the disease.
Enthusiasm regarding the acceleration of technology advances, including retinal monitoring centers, that can be used to help prevent disease progression for patients with eye diseases.
Considerations for using remote monitoring and navigating through the reimbursement process when caring for patients with dry age-related macular degeneration.
The types of data provided by retinal monitoring centers and how to best utilize information provided to better treat patients who have dry age-related macular degeneration.
An overview of the services provided by retinal monitoring centers, and insight on their use by optometrists who have begun using remote monitoring in their clinical practices.
How data from remote monitoring centers create better opportunities for treating patients with dry age-related macular degeneration.
Considerations for using a remote monitoring system for a patient who is diagnosed with intermediate dry age-related macular degeneration.
An overview of the types of strategies that are currently used to screen patients with dry age-related macular degeneration for signs of disease progression
Strategies that can be applied in clinical practice to educate patients with dry age-related macular degeneration on the importance of routine monitoring to prevent disease progression.
Current practices monitoring patients with age-related macular degeneration and insight on how to help reduce out-of-pocket costs for patients during routine follow-ups.
A discussion regarding the clinical benefits of diagnosing age-related macular degeneration early.
Practitioners spend more time diagnosing glaucoma or diabetic retinopathy than AMD
Published: May 4th 2025 | Updated:
Published: September 30th 2021 | Updated:
Published: October 9th 2020 | Updated:
Published: November 1st 2020 | Updated:
Published: January 4th 2024 | Updated:
Published: May 23rd 2023 | Updated: